TrialHuman vaccines & immunotherapeutics2019

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study.

Ki Hwan Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.